Search Results for: MBIO
As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on treatments for the eye.
Published:
If you missed the biotech run and want to try to catch the train this late in the game, it would be wise not to use the new Proshares leveraged biotech ETFs.
Published:
iBio has announced that it has selected a vaccine to advance for the prevention of infection by the coronavirus that causes COVID-19.
Published:
iBio has provided an update on its COVID-19 vaccine manufacturing capacity and said that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals.
Published:
Fears of Ebola have plagued the United States since late September, and some biotech companies have capitalized on this fear.
Published:
If you look through activist investor hedge fund filings, one of the top fund managers and funds to watch is Bruce Berkowitz of Fairholme Capital Management, L.L.C. It is of little surprise that...
Published:
Last Updated:
Davis Selected has bought 5.1% of MBIA (MBI). Just a few days ago, the fund put money into Merrill Lynch (MER). MBIA shares are rising on the news, up 11% to $22.29. The investment is almost...
Published:
Investors fan the flames of Ebola fears in the market, enabling these biotech companies to profit from these fears.
Published:
MBIA Inc. (NYSE: MBI) has tanked after Bank of America Corp. (NYSE: BAC) has tendered for the 5.70% MBIA notes due in 2034. The bank is asking note holders to sell their 2004 MBIA notes to BofA...
Published:
Last Updated:
MBIA (NYSE:MBI) has replaced it CEO with former Chairman and CEO Joseph "Jay" Brown, 59, who retired from the firm last May. Brown expressed some degree of confidence about the...
Published:
MBIA Inc. (NYSE: MBI) has entered into a definitive agreement with global private equity firm Warburg Pincus to invest up to $1 billion in MBIA through a direct purchase of MBIA common stock and a...
Published:
MBIA Inc. (NYSE: MBI) decided to speak out against some recent speculation and some recent reporting on its overall health. The company has said that as a result of Moody’s downgrade of MBIA...
Published:
Ambac (ABK), the bond insurance company is down 19% today to a 52-week low of $30.10. The high for the period is $96.10. Competing firm MBIA (MBI) is already signalling big trouble. According to...
Published:
Moody’s is having a look at the "AAA" rating carried by bond insurance firm MBIA (MBIA). MarketWatch writes that "Bond insurers agree to pay principal and interest when due in a...
Published:
These are five biotech and medtech stocks for very aggressive accounts that look to get shares count leverage on companies that have sizable upside potential.
Published: